13D Filing: Glaxosmithkline Plc and Innoviva Inc. (NASDAQ:INVA)

Page 4 of 6 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: April 13, 2017
                                                                                                                   GLAXOSMITHKLINE PLC
By:
/s/ Victoria A. Whyte                                     
Victoria A. Whyte
Authorized Signatory

Follow Innoviva Inc. (NASDAQ:INVA)